November 4, 2024

Mushrooms hit the ballots as researchers grapple with the dangers of psychedelics

(Washington Times) – Massachusetts could become the third U.S. state to decriminalize psilocybin, the psychedelic drug found in mushrooms, if enough state voters mark “yes” on their ballot’s Question 4. Many drug policy researchers say legalization could be dangerous because … Read More



 
 

October 30, 2024

You tried to tell yourself I wasn’t real’: what happens when people with acute psychosis meet the voices in their heads?

(The Guardian) – In avatar therapy, a clinician gives voice to their patients’ inner demons. For some of the participants in a new trial, the results have been astounding This new therapy demanded that voices were listened to closely, and … Read More



 
 

October 29, 2024

Anti-Obesity Medications Show Whole-Body Promise, With More to Come

(Medscape) – The potential of glucagon-like peptide 1 (GLP-1) receptor agonists continues to grow more promising as new studies identify benefits beyond glucose control and weight loss. With hundreds of studies underway or recently completed on ClinicalTrials.gov, the signals are … Read More



 
 

October 28, 2024

You Are Going to Die

(The Atlantic) – Oliver Burkeman has become an unlikely self-help guru by reminding everyone of their mortality. But Burkeman’s enterprise—to free people from traditional, silver-bullet self-help while selling them his own carefully packaged counsel—is a tricky one. Burkeman himself doesn’t … Read More



 
 

October 22, 2024

Mothering Over Meds: Docs Say Common Treatment for Opioid-Exposed Babies Isn’t Necessary

(KFF Health News) – For decades throughout the opioid crisis, most doctors have relied on medication-heavy regimens to treat babies who are born experiencing neonatal opioid withdrawal syndrome. Those protocols often meant separating newborns from their mothers, placing them in … Read More